Hematology/Oncology Continuing Medical Education (CME) is crucial for medical professionals in the field of blood disorders and cancer. Our programming focuses on molecular oncology, precision medicine in cancer care, early screening and detection, and immunooncology, providing the latest information on personalized cancer therapy in early and late-stages. This comprehensive education covers leukemias (acute myeloid Leukemia, chronic lymphocytic leukemia, lymphomas (Non-Hodgkin’s Lymphoma, follicular lymphoma, mantle cell lymphoma) , multiple myeloma, breast cancer, lung cancers (NSCLC and SCLC), skin cancers (melanoma, NMSC, cSCC, BCC), head and neck cancer, prostate cancer, gastric cancer, anemia management, and blood clotting disorders. The courses offer insights into cancer chemotherapy, hematopoietic stem cell transplantation, immunotherapy in oncology, and personalized medicine in cancer treatment.

These programs are designed for oncologists, hematologists, radiation oncologists, oncology nurses, pathologists, and healthcare providers involved in cancer and blood disorder care. They include updates on molecular genetics in hematologic malignancies, targeted cancer therapies, and management of chemotherapy side effects. Participants engage in case-based learning and discussions on best practices in hematology-oncology and patient communication strategies in oncology.